Ipamorelin 10 mg Research Peptide – Overview
This GMP‑certified peptide is a highly selective growth‑hormone‑releasing hormone (GHRH) analog that stimulates endogenous GH secretion without raising prolactin or cortisol. The Ipamorelin 10 mg Research Peptide delivers ≥ 99 % purity (HPLC) and is endotoxin‑free, making it the go‑to tool for anti‑catabolic, muscle‑growth and body‑composition research.
Key Benefits
- Selective GH release – boosts lean‑mass gain with minimal side‑effects.
- High purity – ≥ 99 % purity confirmed by HPLC.
- Versatile applications – suitable for in‑vitro cell culture, rodent models and ex‑vivo tissue studies.
Technical Specifications
| Specification |
Detail |
| Peptide |
Ipamorelin – 10 mg per vial |
| Purity |
≥ 99 % (HPLC) |
| Form |
Lyophilized powder, amber glass vial (1 mL reconstitution volume) |
| Storage |
–20 °C, desiccated; protect from light & moisture |
| Shelf‑life |
24 months when stored as recommended |
| SKU |
PL‑IPAM‑10‑MG |
| GTIN / UPC |
019876543225 |
| Manufacturer |
PrymaLab |
Reconstitution & Recommended Use
- Reconstitute the vial with **1 mL sterile bacteriostatic water** → final concentration **10 mg / mL** (10 000 µg / mL). This yields a ready‑to‑use solution of the Ipamorelin 10 mg Research Peptide.
- In‑vitro dose: **20‑200 µg/mL** added to culture medium (adjust per assay).
- In‑vivo rodent dose: **0.2‑1 mg/kg** sub‑cutaneously, once daily or twice daily.
- Maximum single dose: **10 mg** per animal per day.
Safety Disclaimer
This product is supplied for **personal, non‑clinical research use only**. It is **not a medication** and does **not** diagnose, treat, cure or prevent any disease. Pregnant or nursing individuals, people with known medical conditions, or anyone taking prescription medication should consult a qualified health professional before use. Keep out of reach of children.